Prostatype Genomics AB
SE0023261532 · Outside a trading venue
3 directors and managers of Prostatype Genomics AB have disclosed 3 transactions under MAR Article 19: 3 buys worth €82k and 0 sells worth €0, which reads as net buying. The most recent disclosed transaction was on 2026-08-31. The largest buy was Anders Liljeblad (closely associated (Yes)) for €50k. See live cluster buys or start a free 14-day trial to get alerts when Prostatype Genomics AB insiders trade.
Insiders
3
Net flow
€82k
Bought
€82k
Sold
€0
Buy Prostatype Genomics AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-31 1mo ago | BUY | Anders Liljeblad closely associated (Yes) | 5,750,000 | €0.01 | €50k |
| 2025-10-03 1y ago | BUY | Håkan Englund Member of the Board of Directors | 525,000 | €0.05 | €24k |
| 2025-10-03 1y ago | BUY | Anders Lundberg Chairman of the Board of Directors | 187,500 | €0.05 | €8k |